...
【24h】

Fabrication of Amphiphilic Hot-Melt Pressure Sensitive Adhesives for Transdermal Drug Delivery

机译:用于透皮药物传递的两亲热熔压敏胶的制备

获取原文
获取原文并翻译 | 示例
           

摘要

Styrene-isoprene-styrene (SIS) copolymer and tackiner resins can be utilized to prepare hot-melt pressure sensitive adhesives (HMPSAs) for the transdermal delivery of high lipophilic drugs. To meet the requirement of transdermal delivery of Chinese medicine (containing different ingredients including lipophilic, amphiphilic and hydrophilic drugs), amphiphilic HMPSAs were developed by melt-blending HMPSAs, poly(ethyl acrylate-co-methyl methacrylate-co-trimethylammonioethyl methacrylate chloride) (RLPO) and polyethylene glycol 2000 (PEG2000). Their morphological structures and miscibility were characterized with phase microscopy and differential scanning calorimetry. Their 180° peel strength and holding power were measured for their adhesive performances. In vitro drug release experiments were carried out using a modified Franz type horizontal diffusion cells, in which three ingredients of gardenia fruit (oleanic acid, luteolin and geniposide) were chosen as representatives of lipophilic, amphiphilic and hydrophilic drugs. It was found that amphiphilic phase structures were developed with the addition of RLPO and PEG2000. As the SIS/RLPO ratio was 1:1~1:2, the HMPSAs had miscible and amphiphilic phase structures. Drug release results showed that hydrophilic drugs could be released due to the existence of RLPO and PEG2000. Its release rate was rapidly enhanced with the increment of RLPO and PEG2000. Meanwhile, the release behavior of lipophilic and amphiphilic drugs and adhesive performance of HMPSAs were preserved in the experiment range. It was proposed that the addition of RLPO and PEG2000 did not destroy phase structures of SIS and tackiner, which insured appropriate adhesive performance and the amphiphilic polymer skeleton of SIS/RLPO/PEG2000 as release channels of various drugs.
机译:苯乙烯-异戊二烯-苯乙烯(SIS)共聚物和增粘树脂可用于制备用于高亲脂性药物透皮递送的热熔压敏胶(HMPSA)。为了满足中药(包含不同成分,包括亲脂性,两亲性和亲水性药物)透皮给药的要求,通过熔融共混HMPSA,聚(丙烯酸乙酯-甲基丙烯酸甲酯-甲基丙烯酸三乙酯-甲基丙烯酸氯乙酯)开发了两亲性HMPSA( RLPO)和聚乙二醇2000(PEG2000)。通过相显微镜和差示扫描量热法对它们的形态结构和混溶性进行了表征。测量其180°剥离强度和保持力的粘合性能。使用改良的Franz型水平扩散池进行体外药物释放实验,其中选择了garden子果实的三种成分(油酸,木犀草素和子苷)作为亲脂性,两亲性和亲水性药物的代表。发现通过添加RLPO和PEG2000,形成了两亲相结构。由于SIS / RLPO比为1:1〜1:2,因此HMPSA具有可混溶和两亲的相结构。药物释放结果表明,由于RLPO和PEG2000的存在,亲水性药物可以释放。随着RLPO和PEG2000的增加,其释放速率迅速提高。同时,在实验范围内保持了亲脂和两亲药物的释放行为和HMPSAs的粘附性能。提出添加RLPO和PEG2000不会破坏SIS和增粘剂的相结构,从而确保适当的粘合性能和SIS / RLPO / PEG2000的两亲聚合物骨架作为各种药物的释放通道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号